Details

Autor(en) / Beteiligte

• Pfaller, Michael A
• Huband, Michael D
• Shortridge, Dee
• Flamm, Robert K

Titel

Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe as Part of the 2016 SENTRY Antimicrobial Surveillance Program

Ist Teil von

• Antimicrobial agents and chemotherapy, 2018-04, Vol.62 (4)

Ort / Verlag

United States: American Society for Microbiology

Erscheinungsjahr

2018

Quelle

EZB Electronic Journals Library

Beschreibungen/Notizen

• Omadacycline was tested against 21,000 bacterial isolates collected prospectively from medical centers in Europe and the United States during 2016. Omadacycline was active against (MIC /MIC , 0.12/0.25 mg/liter), including methicillin-resistant (MRSA); streptococci (MIC /MIC , 0.06/0.12 mg/liter), including , viridans group streptococci, and beta-hemolytic streptococci; , including (MIC /MIC , 0.5/2 mg/liter); (MIC /MIC , 1/1 mg/liter); and (MIC /MIC , 0.25/0.25 mg/liter). Omadacycline merits further study in serious infections where resistant pathogens may be encountered.